Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 17;11(6):1017.
doi: 10.3390/cells11061017.

Aging of the Immune System: Focus on Natural Killer Cells Phenotype and Functions

Affiliations
Review

Aging of the Immune System: Focus on Natural Killer Cells Phenotype and Functions

Ashley Brauning et al. Cells. .

Abstract

Aging is the greatest risk factor for nearly all major chronic diseases, including cardiovascular diseases, cancer, Alzheimer's and other neurodegenerative diseases of aging. Age-related impairment of immune function (immunosenescence) is one important cause of age-related morbidity and mortality, which may extend beyond its role in infectious disease. One aspect of immunosenescence that has received less attention is age-related natural killer (NK) cell dysfunction, characterized by reduced cytokine secretion and decreased target cell cytotoxicity, accompanied by and despite an increase in NK cell numbers with age. Moreover, recent studies have revealed that NK cells are the central actors in the immunosurveillance of senescent cells, whose age-related accumulation is itself a probable contributor to the chronic sterile low-grade inflammation developed with aging ("inflammaging"). NK cell dysfunction is therefore implicated in the increasing burden of infection, malignancy, inflammatory disorders, and senescent cells with age. This review will focus on recent advances and open questions in understanding the interplay between systemic inflammation, senescence burden, and NK cell dysfunction in the context of aging. Understanding the factors driving and enforcing NK cell aging may potentially lead to therapies countering age-related diseases and underlying drivers of the biological aging process itself.

Keywords: aging; cytokines; elderly; frailty; immune system; immunosenescence; inflammation; natural killer cells (NK cells); senescence.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Scheme of NK cell signaling after formation of immunological synapse (IS). Interaction of activating receptor with cognate ligand leads to phosphorylation of cytoplasmic tail and recruitment of PI3K [61,120]. Pathway (A) activation of PI3K and PLC lead to downstream signaling via MAPK and NFκB pathways, respectively, thus facilitating the production and secretion of cytokines, such as IFN-γ. Activation of MAPK signaling also contributes to MTOC migration and the polarization of lytic granules. Pathway (B). Conversion of phosphatidylinositol-4, 5-bisphosphate (PIP2) to phosphatidylinositol-3, 4, 5-triphosphate (PIP3) allows for subsequent generation of the secondary messenger inositol trisphosphate (IP3) via phospholipase C (PLC) [117]. IP3 contributes to the release of internal calcium stores from the smooth endoplasmic reticulum [123], which in turn facilitates mitochondrial migration to IS and influx of extracellular calcium via the ORAI1 transporter [118,119]. Additionally, the microtubule organization center (MTOC) migrates towards the IS and allows for efficient transport of lytic granules (secretory lysosomes) to travel to the IS [124,125]. Lastly, lytic granules fuse with the NK cell membrane in a calcium-dependent manner and release perforin and granzymes into the IS [126]. These proteins form holes in the target cell membrane and induce apoptosis.

Similar articles

Cited by

References

    1. Sierra F. Geroscience and the challenges of aging societies. Aging Med. 2019;2:132–134. doi: 10.1002/agm2.12082. - DOI - PMC - PubMed
    1. Rae M.J., Butler R.N., Campisi J., de Grey A.D., Finch C.E., Gough M., Martin G.M., Vijg J., Perrott K.M., Logan B.J. The demographic and biomedical case for late-life interventions in aging. Sci. Transl. Med. 2010;2:40cm21. doi: 10.1126/scitranslmed.3000822. - DOI - PMC - PubMed
    1. Austad S.N. The Geroscience Hypothesis: Is It Possible to Change the Rate of Aging? In: Sierra F., Kohanski R., editors. Advances in Geroscience. Springer International Publishing; Cham, Switzerland: 2016. pp. 1–36.
    1. Akbar A.N., Gilroy D.W. Aging immunity may exacerbate COVID-19. Science. 2020;369:256–257. doi: 10.1126/science.abb0762. - DOI - PubMed
    1. O’Driscoll M., Ribeiro Dos Santos G., Wang L., Cummings D.A.T., Azman A.S., Paireau J., Fontanet A., Cauchemez S., Salje H. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2021;590:140–145. doi: 10.1038/s41586-020-2918-0. - DOI - PubMed

Publication types

LinkOut - more resources